{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:39:21Z","timestamp":1792028361789,"version":"4.4.0"},"reference-count":120,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Natural Science Foundation of Liaoning province","award":["2022-MS-182"],"award-info":[{"award-number":["2022-MS-182"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Bile acids (BAs) are pivotal signaling molecules that regulate energy metabolism and inflammation. Recent epidemiological studies have reported specific alterations in circulating BA profiles in certain disease states, including obesity, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and Alzheimer disease (AD). In the past decade, breakthroughs have been made regarding the translation of BA profiling into clinical use for disease prediction. In this review, we summarize and synthesize recent data on variation in circulating BA profiles in patients with various diseases to evaluate the value of these biomarkers in human plasma for early diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Acquisition<\/jats:title>\n                  <jats:p>This review is based on a collection of primary and review literature gathered from a PubMed search for BAs, obesity, T2DM, insulin resistance (IR), NAFLD, hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), colon cancer, and AD, among other keywords.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Evidence Synthesis<\/jats:title>\n                  <jats:p>Individuals with obesity, T2DM, HCC, CCA, or AD showed specific alterations in circulating BA profiles. These alterations may have existed long before the initial diagnosis of these diseases. The intricate relationship between obesity, IR, and NAFLD complicates the establishment of clear and independent associations between BA profiles and nonalcoholic steatohepatitis. Alterations in the levels of total BAs and several BA species were seen across the entire spectrum of NAFLD, demonstrating significant increases with the worsening of histological features.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Aberrant circulating BA profiles are an early event in the onset and progression of obesity, T2DM, HCC, and AD. The pleiotropic effects of BAs explain these broad connections. Circulating BA profiles could provide a basis for the development of biomarkers for the diagnosis and prevention of a wide range of diseases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac659","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T18:37:12Z","timestamp":1668451032000},"page":"251-270","source":"Crossref","is-referenced-by-count":48,"title":["Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention"],"prefix":"10.1210","volume":"108","author":[{"given":"Li","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University , Shenyang 110022, Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-8034","authenticated-orcid":false,"given":"Yongsheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shengjing Hospital of China Medical University , Shenyang 110004, Liaoning Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"3","key":"2023011718270084800_dgac659-B1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"issue":"4","key":"2023011718270084800_dgac659-B2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1254\/jphs.13R09CP","article-title":"Inter-organ communication in the regulation of lipid metabolism: focusing on the network between the liver, intestine, and heart","volume":"123","author":"Ito","year":"2013","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"2023011718270084800_dgac659-B3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12017-020-08625-z","article-title":"Bile acids: a communication channel in the gut-brain axis","volume":"23","author":"Monteiro-Cardoso","year":"2021","journal-title":"Neuromolecular Med"},{"issue":"2","key":"2023011718270084800_dgac659-B4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2023011718270084800_dgac659-B5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/1753-0407.13040","article-title":"Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits","volume":"12","author":"Zhu","year":"2020","journal-title":"J Diabetes"},{"key":"2023011718270084800_dgac659-B6","doi-asserted-by":"crossref","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116(3)","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"issue":"2","key":"2023011718270084800_dgac659-B7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/liv.15098","article-title":"Changes in bile acid subtypes and long-term successful weight-loss in response to weight-loss diets: the POUNDS lost trial","volume":"42","author":"Heianza","year":"2022","journal-title":"Liver Int"},{"issue":"4","key":"2023011718270084800_dgac659-B8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bpg.2014.07.004","article-title":"Bile acids, obesity, and the metabolic syndrome","volume":"28","author":"Ma","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"7","key":"2023011718270084800_dgac659-B9","first-page":"901","article-title":"Hepatic bile entry into and transit pattern within the gallbladder lumen: a new quantitative cholescintigraphic technique for measurement of its concentration function","volume":"43","author":"Krishnamurthy","year":"2002","journal-title":"J Nucl Med"},{"issue":"3","key":"2023011718270084800_dgac659-B10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/cphy.c150050","article-title":"Functions of the gallbladder","volume":"6","author":"Housset","year":"2016","journal-title":"Compr Physiol"},{"issue":"8","key":"2023011718270084800_dgac659-B11","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"Ost alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids","volume":"14","author":"Ballatori","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"2023011718270084800_dgac659-B12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0016-5085(75)80146-6","article-title":"Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man","volume":"68","author":"Cowen","year":"1975","journal-title":"Gastroenterology"},{"issue":"4","key":"2023011718270084800_dgac659-B13","doi-asserted-by":"crossref","first-page":"G300","DOI":"10.1152\/ajpgi.00157.2017","article-title":"Determinants of postprandial plasma bile acid kinetics in human volunteers","volume":"313","author":"Fiamoncini","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"2023011718270084800_dgac659-B14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/nu12010047","article-title":"Associations between dietary patterns and bile acids\u2014results from a cross-sectional study in vegans and omnivores","volume":"12","author":"Trefflich","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"2023011718270084800_dgac659-B15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/19490976.2016.1150414","article-title":"Taurocholic acid metabolism by gut microbes and colon cancer","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"2023011718270084800_dgac659-B16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.metabol.2018.02.006","article-title":"Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: a randomized, controlled, crossover feeding study","volume":"83(6)","author":"Ginos","year":"2018","journal-title":"Metabolism"},{"issue":"1","key":"2023011718270084800_dgac659-B17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0016-5085(78)93767-8","article-title":"Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine","volume":"75","author":"Hardison","year":"1978","journal-title":"Gastroenterology"},{"issue":"3","key":"2023011718270084800_dgac659-B18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/alcalc\/agaa005","article-title":"Chronic alcohol consumption increased bile acid levels in enterohepatic circulation and reduced efficacy of irinotecan","volume":"55","author":"Gong","year":"2020","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"2023011718270084800_dgac659-B19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.bjc.6601608","article-title":"Serum bile acids and risk factors for colorectal cancer","volume":"90","author":"van Faassen","year":"2004","journal-title":"Br J Cancer"},{"key":"2023011718270084800_dgac659-B20","doi-asserted-by":"crossref","first-page":"152678","DOI":"10.1016\/j.tox.2021.152678","article-title":"Cigarette smoking exposure breaks the homeostasis of cholesterol and bile acid metabolism and induces gut microbiota dysbiosis in mice with different diets","volume":"450(4)","author":"Yang","year":"2021","journal-title":"Toxicology"},{"issue":"3","key":"2023011718270084800_dgac659-B21","doi-asserted-by":"crossref","first-page":"e0193824","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2023011718270084800_dgac659-B22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol Rev"},{"issue":"5418","key":"2023011718270084800_dgac659-B23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"2023011718270084800_dgac659-B24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molmet.2018.03.007","article-title":"Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas","volume":"11(5)","author":"Kuhre","year":"2018","journal-title":"Mol Metab"},{"issue":"3","key":"2023011718270084800_dgac659-B25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","article-title":"The bile acid chenodeoxycholic acid increases human brown adipose tissue activity","volume":"22","author":"Broeders","year":"2015","journal-title":"Cell Metab"},{"issue":"10","key":"2023011718270084800_dgac659-B26","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J Immunol"},{"issue":"11","key":"2023011718270084800_dgac659-B27","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.3390\/ijms23115935","article-title":"Effects of bile acid modulation by dietary fat, cholecystectomy, and bile acid sequestrant on energy, glucose, and lipid metabolism and gut microbiota in mice","volume":"23","author":"Park","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2023011718270084800_dgac659-B28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol Med"},{"key":"2023011718270084800_dgac659-B29","doi-asserted-by":"crossref","first-page":"108403","DOI":"10.1016\/j.jnutbio.2020.108403","article-title":"Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids","volume":"83(9)","author":"Zhang","year":"2020","journal-title":"J Nutr Biochem"},{"issue":"1","key":"2023011718270084800_dgac659-B30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat Commun"},{"key":"2023011718270084800_dgac659-B31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"issue":"21","key":"2023011718270084800_dgac659-B32","doi-asserted-by":"crossref","first-page":"11629","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2023011718270084800_dgac659-B33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1743-7075-8-48","article-title":"Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults","volume":"8","author":"Cariou","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"2023011718270084800_dgac659-B34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnins.2015.00199","article-title":"Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients","volume":"9","author":"Prinz","year":"2015","journal-title":"Front Neurosci"},{"issue":"5","key":"2023011718270084800_dgac659-B35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1258\/acb.2010.010040","article-title":"Postprandial plasma bile acid responses in normal weight and obese subjects","volume":"47","author":"Glicksman","year":"2010","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"2023011718270084800_dgac659-B36","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1210\/jc.2015-2583","article-title":"Increased bile acid synthesis and impaired bile acid transport in human obesity","volume":"101","author":"Haeusler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023011718270084800_dgac659-B37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.23831","article-title":"Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism","volume":"52","author":"Brufau","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"2023011718270084800_dgac659-B38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.clinbiochem.2014.04.025","article-title":"Correlation between postprandial bile acids and body fat mass in healthy normal-weight subjects","volume":"47","author":"Suzuki","year":"2014","journal-title":"Clin Biochem"},{"issue":"4","key":"2023011718270084800_dgac659-B39","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/clinem\/dgz261","article-title":"Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides\/bile acids in adolescents with obesity","volume":"105","author":"Higgins","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2023011718270084800_dgac659-B40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1515\/cclm-2018-0741","article-title":"Fasting serum bile acids concentration is associated with insulin resistance independently of diabetes status","volume":"57","author":"Lee","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"2023011718270084800_dgac659-B41","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023011718270084800_dgac659-B42","doi-asserted-by":"crossref","first-page":"G549","DOI":"10.1152\/ajpgi.00152.2020","article-title":"Bile acid metabolism and circadian rhythms","volume":"319","author":"Yang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"2023011718270084800_dgac659-B43","doi-asserted-by":"crossref","first-page":"e13943","DOI":"10.1111\/nmo.13943","article-title":"Synthetic G protein-coupled bile acid receptor agonists and bile acids act via basolateral receptors in ileal and colonic mucosa","volume":"32","author":"Tough","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"2023011718270084800_dgac659-B44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/nu13041104","article-title":"Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease","volume":"13","author":"Xie","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"2023011718270084800_dgac659-B45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2265.2010.03886.x","article-title":"The relationship between postprandial bile acid concentration, GLP-1, PYY and ghrelin","volume":"74","author":"Roberts","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7075","key":"2023011718270084800_dgac659-B46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"5","key":"2023011718270084800_dgac659-B47","doi-asserted-by":"crossref","first-page":"e3140","DOI":"10.1002\/dmrr.3140","article-title":"Gall bladder: the metabolic orchestrator","volume":"35","author":"Qi","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"32","key":"2023011718270084800_dgac659-B48","doi-asserted-by":"crossref","first-page":"52775","DOI":"10.18632\/oncotarget.17188","article-title":"Middle-distance running acutely influences the concentration and composition of serum bile acids: potential implications for cancer risk?","volume":"8","author":"Danese","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"2023011718270084800_dgac659-B49","doi-asserted-by":"crossref","first-page":"e122737","DOI":"10.1172\/jci.insight.122737","article-title":"Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans","volume":"3","author":"Morville","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"2023011718270084800_dgac659-B50","doi-asserted-by":"crossref","first-page":"E864","DOI":"10.1152\/ajpendo.00644.2020","article-title":"Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women","volume":"320","author":"Mercer","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2023011718270084800_dgac659-B51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2023011718270084800_dgac659-B52","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.2016-1607","article-title":"Postprandial plasma concentrations of individual bile acids and FGF-19 in patients with type 2 diabetes","volume":"101","author":"Sonne","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2023011718270084800_dgac659-B53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2013-3367","article-title":"Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin","volume":"99","author":"Wewalka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2023011718270084800_dgac659-B54","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"2023011718270084800_dgac659-B55","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1507\/endocrj.EJ20-0201","article-title":"Fasting serum total bile acid levels are associated with insulin sensitivity, islet beta-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes","volume":"67","author":"Wang","year":"2020","journal-title":"Endocr J"},{"issue":"5","key":"2023011718270084800_dgac659-B56","doi-asserted-by":"crossref","first-page":"E782","DOI":"10.1152\/ajpendo.00362.2018","article-title":"Systemic bile acids induce insulin resistance in a TGR5-independent manner","volume":"316","author":"Syring","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2023011718270084800_dgac659-B57","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2337\/dc21-1023","article-title":"Impaired insulin clearance as the initial regulator of obesity-associated hyperinsulinemia: novel insight into the underlying mechanism based on serum bile acid profiles","volume":"45","author":"Fu","year":"2022","journal-title":"Diabetes Care"},{"issue":"2","key":"2023011718270084800_dgac659-B58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2337\/dc20-0884","article-title":"Association of serum bile acids profile and pathway dysregulation with the risk of developing diabetes among normoglycemic Chinese adults: findings from the 4C Study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"2023011718270084800_dgac659-B59","doi-asserted-by":"crossref","first-page":"154042","DOI":"10.1016\/j.metabol.2019.154042","article-title":"Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes","volume":"103","author":"Ch\u00e1vez-Talavera","year":"2020","journal-title":"Metabolism"},{"issue":"22","key":"2023011718270084800_dgac659-B60","doi-asserted-by":"crossref","first-page":"23158","DOI":"10.1074\/jbc.M314322200","article-title":"Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1","volume":"279","author":"Yamagata","year":"2004","journal-title":"J Biol Chem"},{"issue":"33","key":"2023011718270084800_dgac659-B61","doi-asserted-by":"crossref","first-page":"29971","DOI":"10.1074\/jbc.M501931200","article-title":"The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition","volume":"280","author":"Duran-Sandoval","year":"2005","journal-title":"J Biol Chem"},{"issue":"21","key":"2023011718270084800_dgac659-B62","doi-asserted-by":"crossref","first-page":"12848","DOI":"10.1111\/jcmm.15881","article-title":"A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis","volume":"24","author":"Zhao","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"7","key":"2023011718270084800_dgac659-B63","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1096\/fj.11-195701","article-title":"Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition","volume":"26","author":"Renga","year":"2012","journal-title":"FASEB J"},{"issue":"5","key":"2023011718270084800_dgac659-B64","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2018.06.022","article-title":"The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis","volume":"69","author":"Ploton","year":"2018","journal-title":"J Hepatol"},{"issue":"9","key":"2023011718270084800_dgac659-B65","doi-asserted-by":"crossref","first-page":"E1225","DOI":"10.1210\/jc.2015-2467","article-title":"Early increases in bile acids post Roux-en-Y gastric bypass are driven by insulin-sensitizing, secondary bile acids","volume":"100","author":"Albaugh","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023011718270084800_dgac659-B66","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2023011718270084800_dgac659-B67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/tgh.2019.10.02","article-title":"Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis","volume":"5(4)","author":"Sharma","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"7","key":"2023011718270084800_dgac659-B68","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep4.1915","article-title":"Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: data from the United States Scientific Registry of Transplant Recipients","volume":"6","author":"Stepanova","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"2023011718270084800_dgac659-B69","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"issue":"2","key":"2023011718270084800_dgac659-B70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"2023011718270084800_dgac659-B71","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/liv.15030","article-title":"Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus","volume":"41","author":"Jung","year":"2021","journal-title":"Liver Int"},{"issue":"10","key":"2023011718270084800_dgac659-B72","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"2","key":"2023011718270084800_dgac659-B73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"2023011718270084800_dgac659-B74","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6(9)","author":"Verbeke","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2023011718270084800_dgac659-B75","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.jhepr.2020.100222","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"2023011718270084800_dgac659-B76","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"2023011718270084800_dgac659-B77","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2023011718270084800_dgac659-B78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2023011718270084800_dgac659-B79","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"2023011718270084800_dgac659-B80","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","volume":"23","author":"Dasarathy","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2023011718270084800_dgac659-B81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep4.1490","article-title":"Bile acid changes associated with liver fibrosis and steatosis in the Mexican-American population of South Texas","volume":"4","author":"Kwan","year":"2020","journal-title":"Hepatol Commun"},{"key":"2023011718270084800_dgac659-B82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ebiom.2018.12.058","article-title":"Comprehensive molecular and immunological characterization of hepatocellular carcinoma","volume":"40","author":"Shimada","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"2023011718270084800_dgac659-B83","doi-asserted-by":"crossref","first-page":"M110.004945","DOI":"10.1074\/mcp.M110.004945","article-title":"Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"10","author":"Chen","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"2023011718270084800_dgac659-B84","doi-asserted-by":"crossref","first-page":"8984","DOI":"10.1038\/srep08984","article-title":"A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma","volume":"5(3)","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"2023011718270084800_dgac659-B85","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.33236","article-title":"Metabolic perturbations prior to hepatocellular carcinoma diagnosis: findings from a prospective observational cohort study","volume":"148","author":"Stepien","year":"2021","journal-title":"Int J Cancer"},{"key":"2023011718270084800_dgac659-B86","doi-asserted-by":"crossref","first-page":"38180","DOI":"10.1038\/srep38180","article-title":"Increased hepatocellular carcinoma risk in chronic hepatitis B patients with persistently elevated serum total bile acid: a retrospective cohort study","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"2023011718270084800_dgac659-B87","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","article-title":"The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"issue":"8","key":"2023011718270084800_dgac659-B88","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ijc.33885","article-title":"Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma","volume":"150","author":"Stepien","year":"2022","journal-title":"Int J Cancer"},{"issue":"10","key":"2023011718270084800_dgac659-B89","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/ijc.33051","article-title":"Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies","volume":"147","author":"Petrick","year":"2020","journal-title":"Int J Cancer"},{"issue":"11","key":"2023011718270084800_dgac659-B90","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cancers13112648","article-title":"Association between pre-diagnostic serum bile acids and hepatocellular carcinoma: the Singapore Chinese Health Study","volume":"13","author":"Thomas","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"2023011718270084800_dgac659-B91","doi-asserted-by":"crossref","first-page":"M111.010694","DOI":"10.1074\/mcp.M111.010694","article-title":"Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis","volume":"11","author":"Tan","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"2023011718270084800_dgac659-B92","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.29561","article-title":"A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma","volume":"67","author":"Luo","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"2023011718270084800_dgac659-B93","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.7314\/APJCP.2015.16.4.1367","article-title":"Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice","volume":"16","author":"Sombattheera","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"2023011718270084800_dgac659-B94","doi-asserted-by":"crossref","first-page":"105775","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","volume":"205(1)","author":"Zhang","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2023011718270084800_dgac659-B95","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djz166","article-title":"Prediagnostic plasma bile acid levels and colon cancer risk: a prospective study","volume":"112","author":"K\u00fchn","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"2023011718270084800_dgac659-B96","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/cncr.28799","article-title":"A prospective study of serum metabolites and colorectal cancer risk","volume":"120","author":"Cross","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"2023011718270084800_dgac659-B97","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/carcin\/bgl249","article-title":"Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice","volume":"28","author":"Kim","year":"2007","journal-title":"Carcinogenesis"},{"issue":"1","key":"2023011718270084800_dgac659-B98","doi-asserted-by":"crossref","first-page":"G91","DOI":"10.1152\/ajpgi.00027.2015","article-title":"Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling","volume":"311","author":"Sun","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"2023011718270084800_dgac659-B99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07357907.2012.762781","article-title":"Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway","volume":"31","author":"Dai","year":"2013","journal-title":"Cancer Invest"},{"issue":"3","key":"2023011718270084800_dgac659-B100","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"2023011718270084800_dgac659-B101","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"key":"2023011718270084800_dgac659-B102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mam.2017.04.002","article-title":"Bile acids and colon cancer: is FXR the solution of the conundrum?","volume":"56(4)","author":"Gadaleta","year":"2017","journal-title":"Mol Aspects Med"},{"key":"2023011718270084800_dgac659-B103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74(5)","author":"Li","year":"2015","journal-title":"Adv Pharmacol"},{"issue":"2","key":"2023011718270084800_dgac659-B104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2023011718270084800_dgac659-B105","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9(8)","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"issue":"6391","key":"2023011718270084800_dgac659-B106","doi-asserted-by":"crossref","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"issue":"3","key":"2023011718270084800_dgac659-B107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"2023011718270084800_dgac659-B108","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"2023011718270084800_dgac659-B109","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/metabo7020028","article-title":"Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer's disease","volume":"7","author":"Pan","year":"2017","journal-title":"Metabolites"},{"issue":"6","key":"2023011718270084800_dgac659-B110","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.14336\/AD.2020.0217","article-title":"Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer's disease","volume":"11","author":"Shao","year":"2020","journal-title":"Aging Dis"},{"issue":"4","key":"2023011718270084800_dgac659-B111","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease","volume":"45","author":"Olazar\u00e1n","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2023011718270084800_dgac659-B112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-017-1297-5","article-title":"Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease","volume":"14","author":"Marksteiner","year":"2018","journal-title":"Metabolomics"},{"issue":"1","key":"2023011718270084800_dgac659-B113","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease\u2014an emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2023011718270084800_dgac659-B114","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/biom9060232","article-title":"The biosynthesis, signaling, and neurological functions of bile acids","volume":"9","author":"Kiriyama","year":"2019","journal-title":"Biomolecules"},{"key":"2023011718270084800_dgac659-B115","first-page":"598603","article-title":"Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat","volume":"2013(1)","author":"Lali\u0107-Popovi\u0107","year":"2013","journal-title":"J Diabetes Res"},{"issue":"2","key":"2023011718270084800_dgac659-B116","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-210608","article-title":"Bile acids as key modulators of the brain-gut-microbiota axis in Alzheimer's disease","volume":"84","author":"Mulak","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2023011718270084800_dgac659-B117","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3390\/nu12113545","article-title":"Distinct postprandial bile acids responses to a high-calorie diet in men volunteers underscore metabolically healthy and unhealthy phenotypes","volume":"12","author":"Lamaziere","year":"2020","journal-title":"Nutrients"},{"key":"2023011718270084800_dgac659-B118","doi-asserted-by":"crossref","first-page":"154872","DOI":"10.1016\/j.metabol.2021.154872","article-title":"Artificial intelligence and diabetes technology: a review","volume":"124","author":"Gautier","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"2023011718270084800_dgac659-B119","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","volume":"6","author":"Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"2023011718270084800_dgac659-B120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neubiorev.2020.04.026","article-title":"Artificial intelligence and neuropsychological measures: the case of Alzheimer's disease","volume":"114(4)","author":"Battista","year":"2020","journal-title":"Neurosci Biobehav Rev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac659\/47308187\/dgac659.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/2\/251\/48746436\/dgac659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/2\/251\/48746436\/dgac659.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:02:39Z","timestamp":1674014559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/2\/251\/6827486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":120,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2023,1,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac659","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,11,14]]}}}